Last reviewed · How we verify
Placebo eFlow (CS) nebulizer
Placebo eFlow (CS) is a vibrating mesh nebulizer device designed to deliver aerosolized medications to the lungs with enhanced efficiency and patient convenience.
Placebo eFlow (CS) is a vibrating mesh nebulizer device designed to deliver aerosolized medications to the lungs with enhanced efficiency and patient convenience. Used for Placebo control in phase 3 clinical trials for inhaled drug delivery.
At a glance
| Generic name | Placebo eFlow (CS) nebulizer |
|---|---|
| Sponsor | Sunovion Respiratory Development Inc. |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | Phase 3 |
Mechanism of action
The eFlow (CS) nebulizer uses vibrating mesh technology to generate aerosol particles optimized for deep lung penetration. As a placebo formulation in clinical trials, it serves as a control device to evaluate the efficacy of active pharmaceutical agents delivered via this nebulization platform. The device itself is not a drug but rather a delivery system for inhaled therapies.
Approved indications
- Placebo control in phase 3 clinical trials for inhaled drug delivery
Common side effects
Key clinical trials
- Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (PHASE3)
- Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |